The Business Platform for Expanded Access
Jess Rabourn
Co-Founder and Managing Director
WideTrial      |     http://widetrial.org/

Save the Date: Friday, September 15, Cambridge, MA
Dear Friends,
 
We have big news! On September 15, in Cambridge, Massachusetts, selected representatives from pharmaceutical and healthcare industries, patient advocacy, and government will convene for the 2017 Expanded Access Summit.
 
The objective: Determine the current and future best practices for integrating well-designed Expanded Access into the drug development process.
 
The format: We have planned a very focused single-day program of round-table discussion with public involvement. Recordings of the event and early release of the resulting publication will be made available to the participants.
 
How to participate: Registration will begin next week (on or before April 7). Go to http://widetrial.org/summit/  for more details and sign-up instructions.  We have negotiated an excellent guestroom rate at the conference site, the Royal Sonesta Boston.  These rooms may sell out quickly, so we suggest booking soon.

About WideTrial:
WideTrial is a 501c3 non-profit corporation founded on the goal of widening the set of treatment options for sufferers of immediately life threatening diseases.  The organization partners with disease foundations, trial sites, and drug companies to sponsor large-scale Expanded Access trials for meaningful numbers of patients.

STAY CONNECTED: